➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Merck
Colorcon
Moodys
Express Scripts
Dow

Last Updated: August 9, 2020

DrugPatentWatch Database Preview

PIROXICAM - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for piroxicam and what is the scope of freedom to operate?

Piroxicam is the generic ingredient in two branded drugs marketed by Pfizer, Breckenridge, Cadila, Cycle Pharms Ltd, Egis, Flamingo Pharms, Hikma Pharms, Ivax Sub Teva Pharms, Micro Labs, Mylan, Nostrum Labs Inc, SCS, Strides Pharma, Sun Pharm Industries, Teva, Teva Pharms, Unichem Labs Ltd, and Watson Labs, and is included in twenty-four NDAs. Additional information is available in the individual branded drug profile pages.

There are sixteen drug master file entries for piroxicam. Eighteen suppliers are listed for this compound.

Drug Prices for PIROXICAM

See drug prices for PIROXICAM

Drug Sales Revenue Trends for PIROXICAM

See drug sales revenues for PIROXICAM

Recent Clinical Trials for PIROXICAM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Ain Shams UniversityEarly Phase 1
Cairo UniversityN/A
Cairo UniversityEarly Phase 1

See all PIROXICAM clinical trials

Pharmacology for PIROXICAM
Medical Subject Heading (MeSH) Categories for PIROXICAM

US Patents and Regulatory Information for PIROXICAM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Industries PIROXICAM piroxicam CAPSULE;ORAL 073536-002 Jan 23, 2008 DISCN No No   Start Trial   Start Trial   Start Trial
Pfizer FELDENE piroxicam CAPSULE;ORAL 018147-003 Apr 6, 1982 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Breckenridge PIROXICAM piroxicam CAPSULE;ORAL 208991-002 Feb 21, 2018 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for PIROXICAM

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer FELDENE piroxicam CAPSULE;ORAL 018147-003 Apr 6, 1982   Start Trial   Start Trial
Pfizer FELDENE piroxicam CAPSULE;ORAL 018147-003 Apr 6, 1982   Start Trial   Start Trial
Pfizer FELDENE piroxicam CAPSULE;ORAL 018147-002 Apr 6, 1982   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Johnson and Johnson
Merck
Colorcon
McKesson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.